Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: Findings from the TREAT-AF Study

Journal of the American College of Cardiology

Volumn 64, Issue 7, 2014, Pages 660-668

  Turakhia, Mintu P ^a,b   Santangeli, Pasquale ^b,c   Winkelmayer, Wolfgang C ^b   Xu, Xiangyan ^a   Ullal, Aditya J ^a   Than, Claire T ^a   Schmitt, Susan ^a   Holmes, Tyson H ^b   Frayne, Susan M ^a,b   Phibbs, Ciaran S ^a,b   Yang, Felix ^d   Hoang, Donald D ^a   Ho, P Michael ^e,f   Heidenreich, Paul A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Vascular and Endovascular Surgery   (United States)

^e Veterans Affairs Eastern Colorado Healthcare System   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; digoxin; mortality; safety

Indexed keywords

ATRIAL FIBRILLATION; DIGOXIN; MORTALITY; SAFETY;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CAUSE OF DEATH; CONFIDENCE INTERVALS; DIGOXIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OUTPATIENTS; PROGNOSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84905964521     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.060     Document Type: Article

References (34)

1. M.C. Fang, R.S. Stafford, J.N. Ruskin, and D.E. Singer National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation Arch Intern Med 164 2004 55 60 (Pubitemid 38081240)
2. J.L. Anderson, J.L. Halperin, and N.M. Albert et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 1935 1944
3. A.J. Camm, P. Kirchhof, and G.Y. Lip et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
4. A. Ahmed, B. Pitt, and S.H. Rahimtoola et al. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial Int J Cardiol 123 2008 138 146 (Pubitemid 350258580)
5. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
6. S.S. Rathore, J.P. Curtis, and Y. Wang et al. Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 289 2003 871 878 (Pubitemid 37430346)
7. K.E. Chan, J.M. Lazarus, and R.M. Hakim Digoxin associates with mortality in ESRD J Am Soc Nephrol 21 2010 1550 1559
8. L. Friberg, N. Hammar, and M. Rosenqvist Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF) Heart 96 2010 275 280
9. M.G. Whitbeck, R.J. Charnigo, and P. Khairy et al. Increased mortality among patients taking digoxin - analysis from the AFFIRM study Eur Heart J 34 2013 1481 1488
10. P. Hallberg, J. Lindback, and B. Lindahl et al. Digoxin and mortality in atrial fibrillation: a prospective cohort study Eur J Clin Pharmacol 63 2007 959 971 (Pubitemid 47387912)
11. M. Gheorghiade, G.C. Fonarow, and D.J. van Veldhuisen et al. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial Eur Heart J 34 2013 1489 1497
12. M. Turakhia, D.D. Hoang, and X. Xu et al. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study Am Heart J 165 2013 93 101.e1
13. D.C. Cowper, D.M. Hynes, J.D. Kubal, and P.A. Murphy Using administrative databases for outcomes research: select examples from VA Health Services Research and Development J Med Syst 23 1999 249 259 (Pubitemid 29517901)
14. M.W. Smith, and G.J. Joseph Pharmacy data in the VA health care system Med Care Res Rev 60 2003 92S 123S (Pubitemid 36993497)
15. VA Information Resource Center VIReC Research User Guide: VHA Decision Support System Clinical National Data Extracts 2nd ed. 2009 U.S. Dept. of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center Hines, IL
16. N. Arnold, M.-W. Sohn, C. Maynard, and D.M. Hynes VIReC Technical Report 2: VANDI Mortality Data Merge Project 2006 VA Information Resource Center Hines, IL
17. M.W. Sohn, N. Arnold, C. Maynard, and D.M. Hynes Accuracy and completeness of mortality data in the Department of Veterans Affairs Popul Health Metr 4 2006 2
18. J.P. Piccini, M.F. Sinner, and M.A. Greiner et al. Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation Circulation 126 2012 2200 2207
19. M.P. Turakhia, M.D. Solomon, and M. Jhaveri et al. Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation Am Heart J 166 2013 573 580
20. H. Quan, V. Sundararajan, and P. Halfon et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1139 (Pubitemid 41587600)
21. Tarlov E. Applying Comorbidity Measures Using VA and Medicare Data. 2011 VIReC Database and Methods Cyber Seminar Series: VA Information Resource Center, 2011. Available at: http://www.hsrd.research.va.gov/for-researchers/cyber- seminars/archives/vdm-010311.pdf. Accessed November 6, 2013.
22. Healthcare Cost and Utilization Project (HCUP) Clinical Classification Software (CCS) 2012 Agency for Healthcare Research and Quality Rockville, MD
23. A.M. Borzecki, A.T. Wong, and E.C. Hickey et al. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach? Am J Med Qual 19 2004 201 206 (Pubitemid 39329962)
24. B.F. Gage, A.D. Waterman, and W. Shannon et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
25. A.S. Levey, L.A. Stevens, and C.H. Schmid et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
26. Department of Veteran Affairs and Department of Defense VA/DoD Clinical Practice Guideline for Management of Chronic Kidney Disease in Primary Care. Version 2.0 2007 Department of Veteran Affairs, Department of Defense Washington, DC 126
27. L.M. Hess, M.A. Raebel, D.A. Conner, and D.C. Malone Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures Ann Pharmacother 40 2006 1280 1288 (Pubitemid 44204957)
28. J.F. Steiner, T.D. Koepsell, S.D. Fihn, and T.S. Inui A general method of compliance assessment using centralized pharmacy records. Description and validation Med Care 26 1988 814 823
29. J.H. Watanabe, M. Bounthavong, and T. Chen Revisiting the medication possession ratio threshold for adherence in lipid management Curr Med Res Opin 29 2013 175 180
30. D.Y. Lin, B.M. Psaty, and R.A. Kronmal Assessing the sensitivity of regression results to unmeasured confounders in observational studies Biometrics 54 1998 948 963 (Pubitemid 28429289)
31. J. Cohen The t test for means J. Cohen, Statistical Power Analysis for the Behavioral Sciences 1977 Academic Press Toronto, Canada 19 66
32. S.D. Corley, A.E. Epstein, and J.P. DiMarco et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509 1513 (Pubitemid 38420179)
33. J.V. Freeman, J. Yang, S.H. Sung, M.A. Hlatky, and A.S. Go Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure Circ Cardiovasc Qual Outcomes 6 2013 525 533
34. K. Gjesdal, J. Feyzi, and S.B. Olsson Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data Heart 94 2008 191 196 (Pubitemid 351211728)